Contemporary prosthetic heart valves (PHV) are a good mode of treatment of valvular heart
disease. They last for an average of 5 to 10 years and bioprostheses fail due to the tissue …

BACKGROUND: Although surgical intervention is often used in the treatment of prosthetic
valve infective endocarditis (PVIE), an understanding of its effect on survival has been …

Objective: We retrospectively analysed the profile and outcome of surgically treated patients
with active infective prosthetic valve endocarditis (PVE) over a period of 22 years. Methods …

A prospective study of the clinical characteristics and evolutionary patterns of 59 cases of
late prosthetic valve endocarditis (LPVE) that occurred between January 1975 and …

Objective Prosthetic valve endocarditis is a catastrophic complication of cardiac valve
replacement associated with significant morbidity and high mortality. The aim of this study …

BACKGROUND: The risk of death and complications of infective endocarditis (IE) treated
medically has to be balanced against those from surgery in constructing a therapeutic …

We carried out univariate and multivariate analysis of outcome among 122 patients with
prosthetic valve endocarditis (PVE) admitted to our ICU between 1978 and 1992. The …

To evaluate the clinical results and risk factors with prosthetic valve endocarditis (PVE), we
reviewed data on 32 patients who were hospitalized over a period of 10 years because of …

Prosthetic valve endocarditis (PVE) is an important cause of the morbidity and mortality
associated with heart valve replacement surgery. Once established, it carries a mortality rate …